age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
57.10098
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 11
|
$11-$25k
| 0
| 2,784
| 1,590.1895
| 914.3999
| 13
|
white
| 14.599609
| 13
| 0.767944
| 0.519897
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 4
| 104
| 10.599609
| 69
| 24
| 38.09375
| null | null | 0.199982
| 1.099854
| 132
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,000
| 1
|
83.19495
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 1,538
| 1,025.7471
| 985.06982
| 15
|
white
| 24.597656
| 27
| 0.465942
| 0.15097
| 1
| 1
| 0
|
metastatic
| 0.6
| 0.4
|
dnr after sadm
| 1
| 74
| 12.298828
| 77
| 24
| 36.69531
| null | 2.699707
| 0.599976
| 0.899902
| 134
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.966797
| 89
| 1
|
70.82495
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 26
| 5,587
| 3,600.9805
| 3,241.47852
| 9.5
|
white
| 20.597656
| 38
| 0.762939
| 0.622925
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
dnr after sadm
| 1
| 77
| 17.398438
| 71
| 28
| 36.19531
| 236
| null | null | 1.5
| 134
| 7.379883
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,135
| 1
|
69.15295
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 10,159
| 6,785.2852
| 6,877.88672
| 10.5
|
white
| 18
| 29
| 0.843994
| 0.743896
| 4
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 8
| 102
| 11
| 66
| 24
| 35.69531
| 224
| 3.899902
| 0.899902
| 1.199951
| 131
| 7.239258
| null | null | null | null | null | null | 3.24707
| 1,440
| 0
|
73.08398
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 0
| 14,307
| 10,014.0859
| 10,173.5391
| 19
|
white
| 17.898438
| 26
| 0.822998
| 0.762939
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 12
| 75
| 11.298828
| 70
| 24
| 36.39844
| 268
| 3.899902
| 1.099854
| 1.399902
| 137
| 7.389648
| null | null | null | null | 0
| null | 0
| 76
| 1
|
65.396
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 7
| 11
|
under $11k
| 0
| 7,884
| 5,273.1055
| 6,633.85938
| 6
|
white
| 15.298828
| 46
| 0.901978
| 0.835938
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 12
| 79
| 9.599609
| 73
| 28
| 36.39844
| null | 4.599609
| 0.799927
| 3
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 147
| 1
|
75.93695
|
male
| 1
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 6
|
$11-$25k
| 0
| 24,965
| 16,674.9531
| 16,149.3281
| 20.333328
|
white
| 26.398438
| 35
| 0.727905
| 0.574951
| 1
| 1
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 3
| 70
| 12.798828
| 110
| 40
| 37.59375
| 210
| 2.899902
| 0.799927
| 1.399902
| 136
| 7.449219
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 17
| 1
|
54.34399
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 11
|
>$50k
| 0
| 1,509
| 1,049.8047
| 1,218.58984
| 5
|
white
| 18.597656
| 16
| 0.700928
| 0.414978
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.4
|
no dnr
| 3
| 81
| null | 96
| 28
| 35.79688
| null | null | null | null | 140
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 207
| 1
|
73.34698
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 18,090
| 11,908.6641
| 12,040.9531
| 20.5
|
white
| 22
| 22
| 0.765991
| 0.690918
| 6
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 11
| 120
| 23.398438
| 60
| 24
| 36.69531
| 145
| 3.899902
| 0.399963
| 1
| 141
| 7.429688
| null | null | null | null | 5
|
no(M2 and SIP pres)
| 5
| 1,439
| 0
|
77.43195
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 13,719
| null | null | 6.5
|
white
| 8.699219
| 17
| 0.820923
| 0.612915
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.95
|
no dnr
| 12
| 113
| 12.599609
| 76
| 20
| 36.39844
| null | 4.099609
| 0.599976
| 1.199951
| 141
| null | null | null | null | null | null | null | 2.520508
| 432
| 1
|
76.73096
|
female
| 1
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
|
$11-$25k
| 37
| 83,635
| 61,648.1562
| 61,913.9062
| 24.75
|
white
| 39.59375
| 58
| 0.112991
| 0.047997
| 12
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 36
| 53
| 16.398438
| 134
| 12
| 35.59375
| 152
| 2.399902
| 1.799805
| 2.599609
| 146
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 36
| 1
|
61.45398
|
male
| 1
| 35
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 12
|
under $11k
| 9
| 154,093
| 101,554.438
| 115,426.5
| 43.5
|
white
| 29.398438
| 51
| 0.416992
| 0.296997
| 19
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 7
| 73
| 0.199982
| 110
| 30
| 39.5
| 253.3125
| null | null | 1.399902
| 139
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 1.907715
| 35
| 1
|
50.133
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
under $11k
| 0
| 28,895
| 20,353.9219
| 20,749.3125
| 28.666656
|
white
| 22.796875
| 40
| 0.803955
| 0.68396
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 15
| 67
| 11.699219
| 134
| 10
| 39.59375
| 233.3125
| 2.5
| 1.099854
| 0.899902
| 138
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.691895
| 22
| 1
|
85.96295
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 6,391
| 4,357.6367
| 4,165.54688
| 20
|
white
| 26.398438
| 36
| 0.67688
| 0.582886
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 6
| 79
| 23.796875
| 116
| 32
| 38.69531
| 186.65625
| 4.099609
| 0.199982
| 0.699951
| 131
| 7.489258
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,328
| 1
|
69.47797
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 25,801
| 16,894.9688
| 19,424.7656
| 40.5
|
white
| 41.5
| 54
| 0.098999
| 0.040993
| 4
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 7
| 105
| 16.296875
| 120
| 34
| 38.19531
| 86.25
| null | null | 2.699707
| 124
| 7.509766
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 7
| 1
|
70.836
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 7
|
under $11k
| 0
| 3,294
| 1,952.7148
| 1,427.48926
| 7
|
white
| 9
| 20
| 0.826904
| 0.623901
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 4
| 119
| 5.5
| 98
| 24
| 36.5
| null | 4.099609
| 0.399963
| 1.099854
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.772217
| 122
| 1
|
70.86395
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 5,788
| 4,110.832
| 3,670.69922
| 20
|
white
| 21.898438
| 32
| 0.819946
| 0.707886
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 1
| 53
| 10.099609
| 56
| 12
| 38.39844
| null | 2.699707
| 1.799805
| 1
| 133
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 982
| 1
|
80.58295
|
male
| 1
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 22,019
| 14,455.2656
| 14,269.1328
| 29
|
white
| 21.898438
| 32
| 0.747925
| 0.602905
| 1
| 0
| 0
|
no
| 0.5
| 0.1
|
dnr after sadm
| 4
| 70
| 8.599609
| 77
| 30
| 38.29688
| 137.5
| 3.099609
| 0.5
| 0.699951
| 138
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 3.407227
| 14
| 1
|
53.81198
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 4,288
| 3,318.6133
| 3,390.82812
| 2
|
white
| 15.298828
| 11
| 0.762939
| 0.511963
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 113
| 9.099609
| 56
| 20
| 36.19531
| null | 3.699707
| 0.299988
| 1
| 133
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 173
| 1
|
77.58197
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| null | null | 9
| 8,004
| 5,128.5703
| 5,097.39844
| 10
|
white
| 16.898438
| 32
| 0.806885
| 0.687988
| 2
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 6
| 115
| null | 74
| 22
| 36.29688
| 184
| null | null | null | 140
| 7.289062
| null | null | null | null | null | null | 2.940918
| 1,421
| 0
|
54.689
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 0
| 6,362
| 4,323.1992
| 4,391.4375
| 17
|
white
| 26.699219
| 34
| 0.802979
| 0.737915
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 7
| 65
| 3.199707
| 72
| 24
| 36.19531
| null | 2.799805
| 0.299988
| 4.199219
| 135
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,422
| 0
|
66.00397
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 8
| null | 0
| 5,387
| 3,580.7188
| 3,115.80859
| 13
|
white
| 21.097656
| 22
| 0.615967
| 0.300964
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 79
| 7.299805
| 130
| 24
| 38.5
| null | 3.799805
| 0.399963
| 1.099854
| 123
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 104
| 1
|
88.04395
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 9
| 2,461
| 1,665.71
| 1,532.65918
| 6
|
white
| 21.898438
| 34
| 0.718994
| 0.56189
| 1
| 1
| 1
|
no
| 0.25
| 0.25
|
no dnr
| 5
| 102
| null | 83
| 24
| 36
| null | null | 0.299988
| 2.699707
| 132
| null | null | null | null | 6
| 4
|
no(M2 and SIP pres)
| 4
| 100
| 1
|
66.32397
|
male
| 0
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 30,250
| 20,162.25
| 19,742.6562
| 17.333328
|
white
| 20.796875
| 39
| 0.709961
| 0.621948
| 5
| 1
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 19
| 67
| 8.298828
| 65
| 10
| 38.59375
| 85.70312
| 1.799805
| 0.299988
| 1.099854
| 134
| 7.439453
| null | null | null | null | 0
| null | 0
| 902
| 1
|
62.63699
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 0
| 4,544
| 2,984.0488
| 3,243.36914
| 9
|
white
| 20.296875
| 30
| 0.86499
| 0.775879
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 75
| 8.5
| 60
| 20
| 36.59375
| 107.5
| 3.899902
| 0.699951
| 1.199951
| 136
| 7.389648
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 423
| 1
|
74.92096
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 41
| 28,116
| 18,203.4219
| 20,067.8438
| 44
|
white
| 34.09375
| 71
| 0.173981
| 0.087997
| 8
| 1
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 2
| 67
| 0.399963
| 104
| 32
| 39.5
| 265.6875
| 3.199707
| 2
| 2.899902
| 141
| 7.439453
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 6
| 1
|
60.62097
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
>$50k
| 0
| 42,474
| 27,756.9531
| 30,864.4219
| 23
|
white
| 25.097656
| 43
| 0.826904
| 0.718994
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 56
| 19.898438
| 160
| 32
| 36.69531
| 220
| 3.699707
| 0.399963
| 0.699951
| 139
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 36
| 1
|
62.86099
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 13
|
$25-$50k
| 0
| 3,150
| 2,122.1133
| 2,094.81836
| 6
|
white
| 9.599609
| 24
| 0.940918
| 0.898926
| 1
| 1
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 5
| 65
| 7.799805
| 79
| 24
| 36.09375
| 261.875
| 4.699219
| 0.799927
| 0.899902
| 133
| 7.469727
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,417
| 0
|
68.99695
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 3,835
| 2,503.3379
| 2,893.29883
| 3
|
white
| 13.099609
| 19
| 0.908936
| 0.846924
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 6
| 80
| 6.599609
| 101
| 28
| 36.59375
| 307.375
| 4.799805
| 0.299988
| 0.5
| 138
| 7.379883
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.216797
| 1,124
| 1
|
64.85394
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 6,961
| 4,712.75
| 4,549.83984
| 13.5
|
white
| 16.296875
| 39
| 0.897949
| 0.829956
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 132
| 6
| 148
| 28
| 36.09375
| 248.125
| 4.399414
| 0.5
| 1
| 143
| 7.339844
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,410
| 0
|
66.76495
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 0
| 7,166
| 4,621.0664
| 5,069.59766
| 22
|
white
| 19.898438
| 31
| 0.822998
| 0.710938
| 1
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 3
| 107
| 11.898438
| 126
| 24
| 36.5
| 300
| 3.599609
| 0.399963
| 0.899902
| 137
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,411
| 0
|
44.48199
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 15,664
| 10,359.6328
| 10,514.7656
| 18.5
|
white
| 29.898438
| 49
| 0.792969
| 0.724976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 110
| 19.199219
| 142
| 28
| 38.69531
| 173.46875
| 2.599609
| 0.399963
| 2.699707
| 138
| 7.469727
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,410
| 0
|
54.40097
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 13
|
$11-$25k
| 0
| 7,488
| 5,050.7344
| 5,283.14844
| 13
|
white
| 16.5
| 25
| 0.92688
| 0.875977
| 1
| 0
| 0
|
no
| 0.65
| 0.6
|
no dnr
| 7
| 63
| 16.699219
| 107
| 24
| 36.39844
| 204
| 4.199219
| 0.199982
| 0.799927
| 140
| 7.479492
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 260
| 1
|
65.02899
|
male
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 9
| 56,325
| 35,421.8438
| 39,795.4688
| 27.666656
|
white
| 17.398438
| 34
| 0.873901
| 0.790894
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 19
| 113
| 9.099609
| 146
| 30
| 38.29688
| 202.03125
| 4.199219
| 0.599976
| 1.299805
| 134
| 7.469727
| null | null | null | null | null | null | 2.938965
| 1,409
| 0
|
81.48096
|
female
| 1
| 3
|
Coma
|
Coma
| 0
| 16
| null | 100
| 32,997
| 21,490.9688
| 27,210.6562
| 14
|
white
| 21.199219
| 32
| 0.056
| 0.028999
| 27
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 117
| null | 134
| 32
| 38.5
| 377.75
| 3.099609
| 0.699951
| 1.099854
| 131
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.612793
| 3
| 1
|
71.737
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 3,561
| 2,334.3106
| 1,967.94922
| 7
|
white
| 5.799805
| 14
| 0.862915
| 0.69397
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.99
|
no dnr
| 5
| 110
| 7.299805
| 89
| 20
| 35.69531
| null | 4.399414
| 0.199982
| 1
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.791748
| 1,406
| 0
|
80.02197
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
| null | 0
| 1,665
| 1,115.0947
| 1,304.96973
| 18
|
white
| 17.5
| 33
| 0.844971
| 0.744995
| 1
| 1
| 1
|
no
| 0.85
| 0.7
|
dnr after sadm
| 1
| 73
| 4.199219
| 104
| 20
| 35.89844
| 314.25
| 4.099609
| 0.599976
| 1.699951
| 135
| 7.399414
| null | null | null | null | null |
no(M2 and SIP pres)
| 4.041992
| 350
| 1
|
93.41498
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 6,652
| 4,363.7539
| 3,876.33984
| 7.5
|
white
| 18.097656
| 17
| 0.787964
| 0.658936
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr before sadm
| -1
| 85
| 17.898438
| 64
| 24
| 36.29688
| null | 3.399902
| 0.599976
| 0.899902
| 136
| null | null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,325
| 1
|
57.952
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 7
|
$25-$50k
| 0
| 3,660
| 2,429.7559
| 2,444.68945
| 9
|
white
| 10.5
| 16
| 0.826904
| 0.623901
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.3
|
no dnr
| 7
| 63
| 8.599609
| 62
| 24
| 36.09375
| null | 4.099609
| 0.5
| 1.199951
| 133
| null | null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 211
| 1
|
81.11395
|
male
| 0
| 50
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
$11-$25k
| 26
| 91,897
| 61,603.1875
| 62,473.7188
| 40
|
white
| 30.199219
| 58
| 0.307983
| 0.195984
| 9
| 0
| 0
|
yes
| null | null |
no dnr
| 50
| 51
| null | 68
| 28
| 35.89844
| 242.84375
| null | null | 4.799805
| 135
| 7.279297
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 818
| 1
|
73.70294
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 6,145
| 3,975.1602
| 3,636.23828
| 6
|
white
| 20
| 27
| 0.821899
| 0.709961
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 10
| 75
| 14.798828
| 69
| 28
| 35.5
| 240
| null | null | 0.899902
| 138
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,401
| 0
|
64.07898
|
female
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 14
|
under $11k
| 9
| 2,834
| 1,935.4111
| 1,768.78906
| 9
|
white
| 15.599609
| 14
| 0.816895
| 0.605957
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.3
|
no dnr
| 4
| 76
| null | 93
| 16
| 36.29688
| null | null | null | null | 140
| null | null | null | null | null | 0
| null | 0
| 278
| 1
|
58.905
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 15
|
$25-$50k
| 0
| 3,402
| 2,032.0908
| 1,692.66992
| 9
|
white
| 7.099609
| 12
| 0.86499
| 0.696899
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
no dnr
| 5
| 121
| 17.796875
| 96
| 20
| 37.39844
| null | 4.299805
| 0.599976
| 1
| 139
| null | null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 93
| 1
|
52.90097
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 4,159
| 2,839.4883
| 2,726.63867
| 14
|
white
| 17.296875
| 16
| 0.912964
| 0.852905
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 6
| 109
| 9.298828
| 118
| 20
| 36.39844
| null | 3.799805
| 0.299988
| 1.199951
| 136
| null | null | null | null | null | null | null | 3.262695
| 1,379
| 1
|
71.05499
|
female
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 14
|
under $11k
| 0
| 21,861
| 14,073.1797
| 13,974.7734
| 28
|
white
| 24.097656
| 39
| 0.687988
| 0.595947
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 3
| 55
| 14.798828
| 116
| 31
| 38.29688
| 296.625
| 2.799805
| 0.399963
| 1.299805
| 134
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.076172
| 10
| 1
|
76.28998
|
male
| 1
| 4
|
Lung Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 4,655
| 2,850.7129
| 2,189.58984
| 21
|
white
| 25.398438
| 58
| 0.46698
| 0.151978
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 69
| 0.899902
| 126
| 36
| 35.69531
| null | null | null | 0.899902
| 132
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.731934
| 4
| 1
|
64.93097
|
female
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 0
| 85,693
| 57,021
| 59,819.8125
| 35.75
|
white
| 27.898438
| 39
| 0.745972
| 0.665894
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 43
| 74
| 24.296875
| 125
| 42
| 38.09375
| 148
| null | null | 0.799927
| 141
| 7.479492
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,393
| 0
|
73.74896
|
female
| 1
| 9
|
Coma
|
Coma
| 1
| null |
under $11k
| 44
| 21,303
| 14,874.0625
| 15,504.2734
| 29.5
|
white
| 27.699219
| 44
| 0.233978
| 0.168976
| 4
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 9
| 129
| 14.298828
| 114
| 40
| 36.5
| 166
| null | null | 1.5
| 139
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
35.11298
|
female
| 0
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 12,351
| 8,735.1953
| 9,415.82812
| 14.5
|
white
| 30.296875
| 33
| 0.523926
| 0.407959
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 11
| 45
| 1.699951
| 76
| 26
| 37.89844
| null | 3.699707
| 0.5
| 1.199951
| 138
| null | null | null | null | 5
| null |
no(M2 and SIP pres)
| 3.855299
| 106
| 1
|
88.52295
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 11,769
| 7,572.7656
| 6,856.42969
| 39
|
white
| 27.597656
| 41
| 0.563965
| 0.451965
| 1
| 0
| 0
|
yes
| 0.1
| 0.001
|
no dnr
| 6
| 106
| 29.796875
| 70
| 41
| 38
| 110.20312
| 2.899902
| 1.199951
| 1.399902
| 132
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
62.92999
|
male
| 0
| 14
|
Coma
|
Coma
| 1
| 12
| null | 0
| 32,123
| 21,794.6094
| 26,767.9062
| 43.666657
|
white
| 23.5
| 28
| 0.691895
| 0.637939
| 2
| 1
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 14
| 96
| 10.199219
| 102
| 40
| 39.19531
| 164.4375
| 3.599609
| 0.799927
| 1.299805
| 142
| 7.419922
| null | null | null | null | null |
no(M2 and SIP pres)
| 1.665527
| 1,391
| 0
|
58.55197
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,079
| 1,990.9004
| 1,955.76953
| 11
|
white
| 22.097656
| 38
| 0.75293
| 0.494995
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.05
|
no dnr
| 5
| 115
| 5.799805
| 124
| 20
| 36.59375
| null | 3.299805
| 16.796875
| 1.099854
| 135
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 1.841553
| 74
| 1
|
64.24396
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 4,388
| 2,943.1934
| 2,494.30859
| 9
|
white
| 22.097656
| 33
| 0.840942
| 0.73999
| 1
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 6
| 72
| 7.099609
| 48
| 20
| 35.69531
| 323.75
| null | null | 1.699951
| 136
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,390
| 0
|
57.36099
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 16,935
| null | null | 13
|
white
| 24.097656
| 38
| 0.85498
| 0.761963
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 10
| 66
| 11.099609
| 114
| 36
| 39.59375
| 192.5625
| 2.699707
| 1.5
| 1
| 135
| 7.40918
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 1,390
| 0
|
50.18997
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 4
| 12
|
>$50k
| 0
| 3,883
| 2,523.0332
| 2,455.57812
| 9
|
white
| 22.296875
| 18
| 0.630981
| 0.31897
| 1
| 1
| 0
|
metastatic
| 0.2
| 0.05
|
dnr after sadm
| 1
| 77
| 10.398438
| 70
| 20
| 35.69531
| null | 3.299805
| 0.199982
| 0.599976
| 132
| null | null | null | null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 100
| 1
|
62.37399
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 5,885
| 3,970.6641
| 4,407.62891
| 16
|
white
| 19.597656
| 23
| 0.879883
| 0.799927
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 6
| 83
| 8.5
| 101
| 20
| 36.79688
| 180.9375
| 4.299805
| 0.5
| 0.699951
| 127
| 7.449219
| null | null | null | null | null | null | 2.464356
| 1,388
| 0
|
79.07697
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 4,192
| 2,770.7383
| 2,595.36914
| 7
|
white
| 22.398438
| 53
| 0.75
| 0.60498
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 6
| 121
| 5.699219
| 215
| 28
| 36.19531
| 219.03125
| null | null | 1.199951
| 143
| 7.349609
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.876953
| 828
| 1
|
70.48596
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 28,320
| 18,725.5
| 18,765.2656
| 18.666656
|
white
| 37
| 41
| 0.477966
| 0.359985
| 2
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 23
| 65
| 18.597656
| 146
| 38
| 39.39844
| 104.07812
| 2.699707
| 1.5
| 0.5
| 130
| 7.359375
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.195313
| 1,385
| 0
|
71.91498
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 17
|
$25-$50k
| 0
| 5,357
| 3,685.5586
| 3,325.11914
| 9
|
white
| 15.798828
| 16
| 0.78894
| 0.660889
| 1
| 0
| 0
|
no
| 0.9
| 0.95
|
no dnr
| 9
| 95
| 6.899414
| 64
| 24
| 36.69531
| null | 3
| 1.599854
| 1.199951
| 145
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 650
| 1
|
68.35596
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
|
under $11k
| 61
| 56,732
| 37,232.125
| 39,466.4375
| 30.666656
|
white
| 35.09375
| 69
| 0.18399
| 0.095993
| 6
| 0
| 0
|
no
| 0.08
| 0.000512
|
dnr after sadm
| 10
| 113
| 26.699219
| 64
| 28
| 38.19531
| 132
| 2.199707
| 10.798828
| 3
| 141
| 7.429688
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 841
| 1
|
64.06598
|
male
| 0
| 16
|
Lung Cancer
|
Cancer
| 2
| 8
|
$11-$25k
| 0
| 21,757
| 13,109.3281
| 14,360.9375
| 21.666656
|
white
| 10.298828
| 25
| 0.819946
| 0.610962
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 16
| 64
| 8
| 76
| 10
| 38.09375
| 276.1875
| 4
| 0.299988
| 0.699951
| 133
| 7.40918
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,377
| 0
|
70.37097
|
female
| 1
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 98,681
| 67,149.75
| 74,074.8125
| 43
|
white
| 27.796875
| 51
| 0.656982
| 0.55896
| 8
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 42
| 65
| 22.398438
| 72
| 40
| 37.69531
| 100
| 1.699951
| 0.299988
| 0.699951
| 131
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 43
| 1
|
75.52594
|
male
| 1
| 9
|
Coma
|
Coma
| 1
| 10
|
>$50k
| 44
| 79,205
| 53,814.1875
| 50,481.6562
| 36.5
|
white
| 21.398438
| 41
| 0.338989
| 0.265991
| 18
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 8
| 75
| 32.796875
| 68
| 12
| 39.19531
| 204
| 2.299805
| 1.199951
| 1.899902
| 141
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
61.51398
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 8,858
| 5,507.6953
| 5,136.6875
| 13
|
white
| 13.398438
| 19
| 0.779907
| 0.540894
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 1
| 75
| null | 77
| 22
| 37.79688
| null | null | null | 1.399902
| 139
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 107
| 1
|
51.87698
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 12,740
| 8,003.8203
| 10,091.0625
| 13.666664
|
white
| 19.597656
| 33
| 0.897949
| 0.828979
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 15
| 79
| 10.599609
| 98
| 24
| 35.59375
| 361.875
| 4
| 1.399902
| 1.699951
| 135
| 7.459961
| null | null | null | null | 0
| null | 0
| 1,228
| 1
|
40.93597
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 9,355
| 6,916.2422
| 5,496.94922
| 9
|
white
| 34.5
| 53
| 0.72998
| 0.646973
| 1
| 1
| 0
|
no
| 1
| 0.9
|
no dnr
| 10
| 109
| 12.898438
| 108
| 22
| 37.69531
| 93.875
| null | 0.199982
| 7.299805
| 129
| 7.349609
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,371
| 0
|
52.93597
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
>$50k
| 0
| 37,033
| 24,434.8125
| 21,937.4375
| 45.5
|
white
| 53.59375
| 88
| 0.153992
| 0.074997
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 8
| 39
| 16.898438
| 154
| 28
| 39.29688
| 102.84375
| 2.5
| 4.199219
| 3.399902
| 144
| 7.379883
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 11
| 1
|
77.23999
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| 6
|
$11-$25k
| 0
| 19,734
| 14,627.5234
| 11,903.375
| 15.333328
|
white
| 27.898438
| 50
| 0.668945
| 0.572998
| 2
| 1
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 17
| 63
| 13.5
| 124
| 28
| 37.59375
| null | 4
| 0.5
| 2.799805
| 147
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 4.344727
| 168
| 1
|
74.04498
|
male
| 0
| 26
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 75,250
| 48,129.75
| 52,292.5312
| 21.75
|
white
| 22.597656
| 24
| 0.618896
| 0.513916
| 23
| 0
| 0
|
yes
| 0.2
| 0.008
|
dnr after sadm
| 25
| 105
| 5.199219
| 104
| 36
| 36.59375
| 352.5
| null | null | 1.399902
| 141
| 7.769531
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 33
| 1
|
78.33496
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 5
|
$11-$25k
| 0
| 20,412
| 13,551.75
| 13,804.8281
| 21
|
white
| 23.296875
| 47
| 0.73999
| 0.591919
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 1
| 120
| 13.898438
| 59
| 33
| 37.79688
| 180
| 3.799805
| 0.899902
| 2.199707
| 134
| 7.299805
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 267
| 1
|
48.63797
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
$25-$50k
| 100
| 11,142
| 7,791.1289
| 7,995.87891
| 63
|
white
| 50.796875
| 70
| 0.003
| 0
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 3
| 42
| 15.699219
| 68
| 35
| 34.19531
| 110.20312
| 2
| 1.899902
| 2.599609
| 154
| 7.539062
| null | null | null | null | null |
<2 mo. follow-up
| 4.214844
| 3
| 1
|
74.52197
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 9
| 4,039
| 2,678.4492
| 3,494.80859
| 7
|
white
| 14.898438
| 18
| 0.858887
| 0.767944
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 1
| 79
| 8.298828
| 73
| 24
| 35.89844
| 186.65625
| 4.099609
| 0.399963
| 0.699951
| 140
| 7.389648
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 794
| 1
|
29.97899
|
male
| 0
| 73
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 9
| 123,456
| 92,438
| 91,346.0625
| 16.5
|
white
| 20.796875
| 23
| 0.841919
| 0.787964
| 20
| 0
| 0
|
yes
| 0.75
| 0.7
|
no dnr
| 73
| 77
| 14.5
| 126
| 30
| 37.79688
| 240
| 2.599609
| 0.399963
| 0.899902
| 141
| 7.389648
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,362
| 0
|
52.02197
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 15,758
| 10,225.4141
| 10,733.2656
| 22.5
|
white
| 17.796875
| 21
| 0.828979
| 0.628906
| 1
| 0
| 0
|
metastatic
| 1
| 0.1
|
no dnr
| 10
| 113
| 10
| 70
| 10
| 35.79688
| 282
| null | null | 0.799927
| 135
| 7.479492
| null | null | null | null | null | null | 2.312988
| 1,361
| 0
|
71.00598
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 17
|
under $11k
| 0
| 3,023
| 2,051.9375
| 1,920.01953
| 6
|
white
| 45
| 52
| 0.272949
| 0.103989
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 6
| 29
| 5.799805
| 59
| 24
| 37
| null | 3.099609
| 0.599976
| 5
| 132
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
63.918
|
male
| 0
| 40
|
Coma
|
Coma
| 4
| null | null | 61
| 60,050
| 77,295.875
| 85,570.625
| 36.5
|
white
| 23.199219
| 27
| 0.440979
| 0.366943
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
dnr after sadm
| 3
| 61
| 17.597656
| 78
| 6
| 37.89844
| 94.28125
| 2.799805
| 1.699951
| 1.199951
| 139
| 7.579102
| null | null | null | null | null | null | 2.715332
| 65
| 1
|
79.31799
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 6
| null | 44
| 10,346
| 6,697.7539
| 10,274.2031
| 21
|
white
| 28.296875
| 75
| 0.212982
| 0.066986
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 1
| 57
| 5.299805
| 112
| 36
| 39.59375
| 485.6875
| 1.699951
| 2.699707
| 2.099609
| 148
| 7.469727
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 14
| 1
|
75.58698
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
|
$11-$25k
| 0
| 2,641
| 1,807.6631
| 1,603.5293
| 11
|
white
| 17.699219
| 32
| 0.855957
| 0.762939
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 75
| 8.898438
| 70
| 20
| 35.69531
| null | 3.699707
| 1.899902
| 1.5
| 136
| null | null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 809
| 1
|
65.875
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 11
|
under $11k
| 0
| 5,483
| 3,792.6484
| 3,592.72852
| 10
|
white
| 24.699219
| 28
| 0.522949
| 0.200989
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 5
| 71
| 22.898438
| 67
| 26
| 35.09375
| null | 3.799805
| 0.5
| 0.899902
| 124
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.420898
| 1,350
| 0
|
60.53897
|
female
| 1
| 3
|
Coma
|
Coma
| 1
| null | null | 0
| 42,868
| 27,519.3594
| 26,107.1094
| 59
| null | 46
| 66
| 0.084991
| 0.048996
| 6
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 43
| 17.699219
| 140
| 12
| 38.69531
| 132.71875
| null | null | 5.299805
| 130
| 7.319336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 3
| 1
|
72.34998
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 100
| 112,532
| 79,493.25
| 77,019.1875
| 29.75
|
white
| 21.097656
| 41
| 0.327942
| 0.212982
| 13
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 42
| 69
| 10.199219
| 78
| 40
| 39.89844
| 240
| null | null | 1.699951
| 146
| 7.469727
| null | null | null | null | 0
| null | 0
| 1,349
| 0
|
78.80396
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 4,893
| 3,245.4336
| 3,003.36914
| 10.5
|
white
| 21
| 24
| 0.638916
| 0.458984
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
dnr after sadm
| 1
| 97
| 4.5
| 74
| 16
| 35.19531
| null | 3.599609
| 0.699951
| 1.799805
| 133
| null | null | null | null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 258
| 1
|
87.70398
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 9,576
| 6,121.2734
| 5,868
| 13
|
white
| 16.398438
| 42
| 0.738892
| 0.589966
| 1
| 0
| 0
|
yes
| 0.6
| 0.5
|
dnr after sadm
| 1
| 103
| 6.399414
| 96
| 28
| 38
| 204.75
| 3.799805
| 1.099854
| 1.5
| 139
| 7.379883
| null | null | null | null | null | null | 4.556641
| 380
| 1
|
54.52197
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 81,712
| 49,968.125
| 51,202.75
| 21.333328
|
white
| 24.296875
| 24
| 0.717896
| 0.631958
| 38
| 0
| 0
|
yes
| 0.5
| 0.2
|
no dnr
| 20
| 75
| 4.899414
| 126
| 28
| 36.29688
| 346.9375
| null | null | 1.099854
| 140
| 7.439453
| null | null | null | null | 5
| null | 5
| 137
| 1
|
75.30194
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 2
| 8
|
$11-$25k
| 0
| 11,949
| 7,253.4805
| 7,676.88672
| 17
|
white
| 16.296875
| 24
| 0.807983
| 0.589966
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 8
| 73
| 5.399414
| 96
| 24
| 38.09375
| null | null | null | 1.299805
| 132
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 632
| 1
|
65.17499
|
male
| 0
| 28
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 26
| 31,065
| 19,741.4375
| 19,872.3594
| 17
|
white
| 26
| 39
| 0.707886
| 0.547974
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 1
| 79
| 7.899414
| 103
| 36
| 37.89844
| 185.6875
| 2.399902
| 0.599976
| 1
| 138
| 7.469727
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,347
| 0
|
22.88799
|
male
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 0
| 54,848
| 37,453.5625
| 39,282.1562
| 27
|
white
| 35.195313
| 62
| 0.730957
| 0.647949
| 10
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 40
| 63
| 21.796875
| 140
| 50
| 36.09375
| 182.84375
| 2
| 3.5
| 0.399963
| 137
| 7.449219
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 604
| 1
|
61.30899
|
male
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 135,370
| 82,462.5
| 88,001.9375
| 21.5
|
white
| 29.199219
| 36
| 0.572998
| 0.462952
| 28
| 0
| 0
|
yes
| null | null |
no dnr
| 31
| 116
| 0.099991
| 112
| 24
| 36.19531
| 353
| null | null | 1.199951
| 135
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 730
| 1
|
62.073
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 6,530
| 4,838.1602
| 5,611.51953
| 2
|
white
| 4.399414
| 20
| 0.886963
| 0.74292
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 115
| 14.699219
| 73
| 24
| 36.29688
| 357.125
| 4.599609
| 0.399963
| 1.199951
| 134
| 7.459961
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.161133
| 68
| 1
|
63.22198
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 6,315
| null | null | 7
|
white
| 14.5
| 17
| 0.757935
| 0.50293
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 5
| 75
| 6.699219
| 83
| 18
| 36.39844
| null | null | null | 1.099854
| 136
| null | null | null | null | null | null | null | 1.941162
| 632
| 1
|
81.21594
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 18,554
| 13,085.6641
| 13,771.9297
| 32
|
white
| 25.898438
| 42
| 0.578979
| 0.468994
| 4
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 4
| 59
| 77.390625
| 58
| 30
| 36.79688
| 155.09375
| null | null | 1.5
| 138
| 7.339844
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
68.43799
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 12,932
| 7,977.168
| 7,868.26953
| 19
|
white
| 18.199219
| 23
| 0.793945
| 0.563965
| 1
| 1
| 0
|
metastatic
| 0.98
| 0.8
|
no dnr
| 9
| 113
| 12.599609
| 76
| 16
| 36.19531
| null | null | null | 1.599854
| 137
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,335
| 0
|
59.53198
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 9,529
| 6,561.9961
| 6,822.88672
| 29
|
white
| 37.296875
| 77
| 0.242981
| 0.140991
| 2
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 5
| 61
| 9.699219
| 120
| 28
| 36.39844
| 207.5
| 1.699951
| 15.5
| 4.099609
| 135
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
76.70599
|
male
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 44
| 46,129
| 29,804.6719
| 32,551.4844
| 38.333313
|
white
| 31
| 44
| 0.337952
| 0.15097
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 15
| 70
| 15.898438
| 116
| 40
| 38.29688
| 215
| 1.799805
| 0.299988
| 1
| 140
| 7.389648
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 18
| 1
|
73.26996
|
female
| 0
| 46
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 26
| 65,771
| 44,039.9375
| 44,007.4688
| 27
|
white
| 27.699219
| 41
| 0.590942
| 0.398987
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 30
| 55
| 7.299805
| 71
| 8
| 37.59375
| 187.5
| 2.799805
| 0.899902
| 2.5
| 142
| 7.669922
| null | null | null | null | null | null | 3.068359
| 1,335
| 0
|
53.66199
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 11
| null | 26
| 5,210
| 3,389.5176
| 3,521.0293
| 12
|
white
| 24.597656
| 8
| 0.435974
| 0.127991
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 1
| 104
| 3.399902
| 69
| 24
| 37
| 344.4375
| 2.599609
| 0.399963
| 0.699951
| 142
| 7.40918
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.515137
| 90
| 1
|
81.62598
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 7
| null | 9
| 4,685
| 3,020.8144
| 3,273.85938
| 18
|
white
| 15.599609
| 36
| 0.768921
| 0.632935
| 1
| 0
| 1
|
yes
| 0.5
| 0.5
|
no dnr
| 7
| 74
| 4.899414
| 81
| 24
| 36.09375
| 233.3125
| null | null | 0.899902
| 145
| 7.379883
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 180
| 1
|
43.63898
|
male
| 0
| 35
|
Coma
|
Coma
| 0
| 12
|
$25-$50k
| 100
| 22,306
| 27,158.3594
| 28,949.3125
| 22.75
|
white
| 23.5
| 23
| 0.438965
| 0.365967
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 11
| 114
| 25.796875
| 74
| 34
| 36.09375
| 445
| 2.699707
| 0.899902
| 0.699951
| 129
| 7.5
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 39
| 1
|
69.47797
|
female
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$25-$50k
| 0
| 11,658
| 7,918.2812
| 7,724.65625
| 12
|
white
| 17
| 20
| 0.878906
| 0.79895
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 15
| 65
| null | 63
| 20
| 36
| null | null | null | 1.199951
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,329
| 0
|
76.96594
|
male
| 0
| 51
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 158,804
| 111,121.562
| 106,241.5
| 30
|
white
| 18.898438
| 32
| 0.620972
| 0.515991
| 30
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 16
| 79
| 11.699219
| 80
| 40
| 38.69531
| 223.3125
| null | null | 1.399902
| 146
| 7.439453
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 85
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.